THE WHAT? Novo Nordisk has begun broad US distribution of Wegovy capsule, the primary oral GLP-1 remedy accepted for continual weight administration in adults with weight problems or chubby with associated medical circumstances. THE DETAILS The once-daily oral formulation of semaglutide obtained FDA approval on December 22, 2025 and is now obtainable by means of […]
Novo Nordisk lowered its gross sales forecast for weight problems drug Wegovy, citing competitors from compounded variations. Scott Olson/Getty Pictures cover caption toggle caption Scott Olson/Getty Pictures Novo Nordisk’s shares plunged greater than 20% Tuesday, after the corporate reduce the forecast for its flagship weight problems drug. Earlier than the markets opened, the firm introduced […]
